Jan 2026· Depression and Anxiety· Vol 2026· 0 citations· 58 references
Medicine
TL;DR
Recorded trauma/stressor exposure was associated with the high overall symptom profile, whereas neuroendocrine markers showed limited incremental value, highlighting multidimensional symptom profiling and trauma assessment in adolescent depression.
Abstract
Background Adolescent major depressive disorder (MDD) is clinically heterogeneous, with sleep disturbance often emerging as a prominent but variably expressed symptom dimension. This study aimed to identify latent symptom profiles in drug‐naïve adolescents with MDD and examine their associations with recorded trauma/stressor exposure and neuroendocrine markers. Methods This cross‐sectional study included 711 drug‐naïve adolescents with MDD. Latent profile analysis (LPA) was conducted using 16 symptom indicators derived from the Hamilton depression rating scale (HDRS), Hamilton anxiety rating scale (HAMA), and Pittsburgh sleep quality index (PSQI). Multinomial logistic regression examined associations of recorded trauma/stressor exposure and neuroendocrine markers with profile membership. Results A three‐profile solution was retained: low overall symptoms (Profile 1; n = 200, 28.1%), PSQI‐elevated subjective sleep disturbance (Profile 2; n = 215, 30.2%), and high overall symptoms (Profile 3; n = 296, 41.6%). Recorded family trauma/stressor exposure and violent incident exposure were associated with higher odds of Profile 3 membership relative to Profile 1, and these associations remained significant after neuroendocrine markers were added. Higher standardized testosterone (T) showed a modest association with Profile 3 membership, whereas FT3 showed only a marginal association. However, adding neuroendocrine markers did not significantly improve model fit beyond trauma‐related variables. Conclusion LPA identified three clinically interpretable symptom profiles in adolescent MDD, including a profile characterized primarily by elevated PSQI‐assessed subjective sleep disturbance. Recorded trauma/stressor exposure was associated with the high overall symptom profile, whereas neuroendocrine markers showed limited incremental value. These findings highlight multidimensional symptom profiling and trauma assessment in adolescent depression, while suggesting that neuroendocrine findings should be considered exploratory.
BACKGROUND
Co-occurring depressive and anxiety symptoms in adolescents are associated with functional impairment. However, few studies have examined how family functioning, peer problems, emotion dysregulation, and mental health knowledge relate to the severity profiles of these symptoms.
METHODS
A total of 3981 adol...
Jie Zhao, Jing-Lin Ni, Yang Xu et al.· Journal of Affective Disorde...· 0 citations
BACKGROUND
Depressive and anxiety symptoms frequently persist during stable phases of bipolar disorder (BD), yet their interconnected architecture remains unclear. This study examined the prevalence, clinical correlates, and network structure of these symptoms in patients with BD.
METHODS
We evaluated 9455 clinically...
Yu-Ying Zhang, Jing-Song Ma, Yue Wu et al.· Journal of Affective Disorde...· 0 citations
A neuroimmune profile characterized by proinflammatory activity and insufficient, fragmented sleep functioned as a distal risk factor of MDD symptoms and a person-centered, multimodal risk stratification approach may enhance targeted prevention of long-term MDD.
Nur Hani Hani Zainal, S. Beaudreau· Brain, Behavior, & Immunity...· 0 citations
Findings suggest that ANPS SADNESS and CARE may inform personalized treatment approaches in youths with major depressive episodes; however, the retrospective single-center design limits causal inference and the Korean ANPS remains in early stages of psychometric validation in adolescents, underscoring the need for pros...
Dohyeong Lee, Minseok Lee, K. Davis et al.· Journal of child and adolesc...· 0 citations
These findings support the relevance of sensory traits as potential clinical markers and therapeutic targets and suggest personalized interventions addressing sensory processing may contribute to improved treatment outcomes.
A. Paquet, Lucia Fiegl, B. Plansont et al.· Depression and Anxiety· 1 citation
Insomnia symptoms are highly prevalent and burdensome among patients with MDD, severely affecting daily life and perceived treatment success, and the need for integrated treatment strategies targeting both mood and sleep symptoms is emphasized.
Joshua M. Hamilton, Emilie Pain, J. Riise et al.· Interactive Journal of Medic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.